US BROKER MOVES: BE upgraded at Barclays; MRVL downgraded at TD Cowen

• Afya (AFYA) Upgraded from Neutral to Buy at Citi; PT USD 16
• Aon (AON) Upgraded from Market Perform to Outperform at BMO Capital; PT USD 380
• Bloom Energy (BE) Upgraded from Equalweight to Overweight at Barclays; PT USD 289
• Ibotta (IBTA) Upgraded from Sell to Neutral at Goldman Sachs; PT USD 58
• Marsh McLennan (MRSH) Upgraded from Market Perform to Outperform at BMO Capital; PT USD 230
• Cloudflare (NET) Upgraded from Neutral to Overweight at JPMorgan; PT USD 350
• onsemi (ON) Upgraded from Hold to Buy at Craig-Hallum; PT USD 85
• Strattec Security (STRT) Upgraded from Hold to Buy at Freedom Broker; PT USD 79
• Tempus AI (TEM) Upgraded from Underperform to Hold at Jefferies; PT USD 70
• Twilio (TWLO) Upgraded from Reduce to Hold at HSBC; PT USD 215

• Arthur J. Gallagher (AJG) Downgraded from Outperform to Market Perform at BMO Capital; PT USD 295
• Chevron (CVX) Downgraded from Buy to Hold at DZ Bank; PT USD 240
• D.R. Horton (DHI) Downgraded from Market Perform to Underperform at Raymond James
• Coca-Cola FEMSA (KOF) Downgraded from Outperform to Market Perform at Itaú BBA; PT USD 116
• Lumentum (LITE) Downgraded from Buy to Neutral at B. Riley; PT USD 770
• ManpowerGroup (MAN) Downgraded from Outperform to Neutral at BNP Paribas Exane; PT USD 52.50
• Mistras Group (MG) Downgraded from Buy to Neutral at Roth/MKM; PT USD 20.35
• monday.com (MNDY) Downgraded from Buy to Hold at TD Cowen; PT USD 105
• Medical Properties Trust (MPT) Downgraded from Outperform to Neutral at BNP Paribas Exane; PT USD 2.25
• Meridian Corporation (MRBK) Downgraded from Buy to Neutral at DA Davidson
• Merck & Co. (MRK) Downgraded from Buy to Hold at DZ Bank; PT USD 153
• Marvell Technology (MRVL) Downgraded from Buy to Hold at TD Cowen; PT USD 175
• Once Upon A Farm (OFRM) Downgraded from Buy to Underperform at BofA Securities; PT USD 10
• Roku (ROKU) Downgraded from Buy to Neutral at Rosenblatt
• Verra Mobility (VRRM) Downgraded from Neutral to Underweight at JPMorgan

• AIRO Group (AIRO) Initiated at Buy at Roth/MKM; PT USD 16
• nLight (LASR) Initiated at Buy at Needham; PT USD 50
• MNTN (MNTN) Initiated at Buy at Freedom Broker; PT USD 16.50
• Pony AI (PONY) Initiated at Overweight at Morgan Stanley; PT USD 10
• Powerus (PUSA) Initiated at Outperform at Northland; PT USD 5
• Retension Pharmaceuticals (RTSN) Initiated at Outperform at Leerink; PT USD 50
• Retension Pharmaceuticals (RTSN) Initiated at Outperform at Oppenheimer; PT USD 50
• Sportsman's Warehouse (SPWH) Initiated at Buy at Ladenburg Thalmann
• TRex Bio (TRXB) Initiated at Overweight at Cantor Fitzgerald
• TRex Bio (TRXB) Initiated at Outperform at Evercore ISI; PT USD 28
• TRex Bio (TRXB) Initiated at Overweight at JPMorgan; PT USD 20
• TRex Bio (TRXB) Initiated at Buy at Stifel; PT USD 39

A broad daily sweep of broker actions rather than a single signal, and the historical read on such bundles is that the moves worth isolating are the ones where a shop reverses a high-conviction stance or where multiple houses move the same name or the same theme at once. Here the cluster to note is insurance brokers: BMO split its coverage, lifting Aon and Marsh McLennan while cutting Arthur J. Gallagher to market perform, a relative-value reshuffle within the peer set that has typically mattered more than any individual rating since it signals a view on pricing and margin dispersion rather than on the subsector itself. The semiconductor tape also carries a split, with onsemi upgraded at a smaller house while Marvell and monday.com are cut at TD Cowen, and divergent calls within a crowded theme have tended to resolve around positioning and estimate revision breadth rather than the ratings themselves. Single-name, single-shop changes in isolation have historically faded within sessions unless they front-run an earnings revision or a corporate catalyst; initiations with no prior coverage, as with the biotech names here, tend to have the shortest shelf life of all. The follow-ons that have mattered in past episodes are whether the target changes are accompanied by estimate moves, whether peer houses follow within days, and whether any of the rated names have results on the near calendar that would make the call a positioning statement. As a compilation, the information content is distributional, not directional.